Global Healthcare Contract Research Outsourcing Market Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2027
![]() |
| Healthcare Contract Research Outsourcing Market |
The Pharmaceutical and Medical Device
industries are gradually moving away from integrated process models toward
outsourcing models, where businesses in these industries contract out a variety
of tasks to contract research outsourcing firms, including clinical trials,
medical writing, and regulatory processes.
During the forecast period, the
small to mid-sized pharmaceutical, biotechnology, and medical device companies
are expected to receive increased funding, which will encourage them to choose
CRO services with a focus on niche markets. This is expected to drive the
market for healthcare contract research outsourcing to experience strong
growth. The expansion of the variety of services and solutions provided by
CROs, as well as the internationalisation of clinical trials, are all
contributing to the rapid growth of the global healthcare contract research
outsourcing market. During the forecast period, increased availability to
specialised technology and treatments knowledge is anticipated to drive use of
clinical trial services in North America.
According to Coherent Market Insights, The global Healthcare
Contract Research Outsourcing Market was valued at US$ 74.7 Bn in
2019 and is forecast to reach a value of US$ 229.2 Bn by 2027 at a CAGR of
15.1% between 2020 and 2027.
The increase in efforts to reduce
costs and speed up the drug development process, the growth of the variety of
services and solutions offered by CROs, and the globalisation of clinical
trials are just a few of the factors driving the anticipated growth of the
global healthcare contract research outsourcing market. In the market for Healthcare Contract Research Outsourcing
Market, some of the crucial services include regulatory, clinical trial,
pharmacovigilance, site management protocol, and medical writing. These
services are mostly employed by pharmaceutical, academic, government, and
medical device industries as well as biotechnology and pharmaceutical companies
worldwide.
According to estimates, the
demand for outsourcing regulatory services would rise, which will affect
businesses in the worldwide healthcare contract research outsourcing market.
This surge is attributable to increased regulatory agency scrutiny of clinical
studies at all phases, particularly by the EMA and FDA. Additionally, it is
anticipated that shifting regulatory requirements in each location will provide
potential for outsourcing regulatory services.
In order to maintain their dominant
market positions and increase their presence in more recent locations,
businesses in the healthcare contract research outsourcing industry are getting
into acquisition and collaboration agreements. In order to attract customers,
some of the major competitors in the global Healthcare Contract Research Outsourcing Market are concentrating
on providing top-notch services. As CROs are familiar with the regulatory needs
of numerous locations, outsourcing increases the worldwide reach of drug
development while requiring the least amount of maintenance, which is causing
the market for healthcare contract research outsourcing to grow. To effectively
and efficiently utilise the development skills abroad, healthcare corporations
frequently outsource drug development responsibilities to contract research
groups.
Major Companies involved are- IQVIA, Covance, Inc., Pharmaceutical
Product Development Inc., Parexel International Corporation, Charles River
Laboratories International Inc., Icon, Plc, Medidata Solutions, Inc., Inventiv
Health, Inc. (Pharmanet Development Group Inc.), Medpace Holdings, Inc., and
Piramal Life Sciences.
Get the Press Release of Global Healthcare Contract Research
Outsourcing Market -https://www.coherentmarketinsights.com/press-release/healthcare-contract-research-outsourcing-market-3054

Comments
Post a Comment